Skip to main content
OpenTrials

Clinical trial condition

Kidney Diseases

Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.

8,805 public trials 1,412 recruiting studies
Refine in advanced search Browse all conditions

Kidney Diseases trial results

Active, Not Recruiting

Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)

NCT04106349

Conditions
Adenocarcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, +14 more
Locations
  • Onze-Lieve-vrouw Ziekenhuis Aalst Aalst, Belgium
  • Imeldaziekenhuis Bonheiden, Belgium
  • Clinique Saint-Luc Bouge Bouge, Belgium
  • AZ Sint-Jan Brugge Bruges, Belgium
View all 20 locations
View Trial Details
Active, Not Recruiting

Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)

NCT04626479

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of California at San Francisco ( Site 1008) San Francisco, California, United States
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 1011) New Haven, Connecticut, United States
  • University of Chicago ( Site 1013) Chicago, Illinois, United States
  • University of Iowa ( Site 1012) Iowa City, Iowa, United States
View all 55 locations
View Trial Details
Active, Not Recruiting

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

NCT03647878

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • Landeskrankenhaus Hochsteiermark Leoben, Austria
  • Kepler Universitätsklinikum GmbH Linz, Austria
  • Uniklinikum Salzburg Salzburg, Austria
  • Salzkammergutklinikum Vöcklabruck Vöcklabruck, Austria
View all 82 locations
View Trial Details
Active, Not Recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Lake City, Florida, United States
  • Research Site Hinsdale, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

NCT05198674

Conditions
Cardiovascular Diseases, Chronic Disease, Chronic Kidney Diseases, +18 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Banner Heart Hospital Mesa, Arizona, United States
  • Abrazo Arizona Heart Hospital/Biltmore Cardiology Phoenix, Arizona, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
View all 99 locations
View Trial Details
Active, Not Recruiting

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

NCT03793166

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 860 locations
View Trial Details
Active, Not Recruiting

Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

NCT07161037

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease (ADPKD), Ciliopathies, +12 more
Locations
  • Alabama Kidney Research Alabaster, Alabama, United States
  • UAB Nephrology Research at CH19 Birmingham, Alabama, United States
  • Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
  • UCSF Clinical Research Center at Parnassus San Francisco, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

NCT06926660

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +10 more
Locations
  • Apogee Clinical Research Huntsville, Alabama, United States
  • Orange County Clinical Trials Anaheim, California, United States
  • North America Research Institute San Dimas, California, United States
  • Valiance Clinical Research-Tarzana-68237 Tarzana, California, United States
View all 157 locations
View Trial Details

Related conditions